As of September 11, 2026, Ulta Beauty, Inc. (ULTA) trades at $546.65. CleaRank Financial AI rates it Buy with a fair value of $635.00, 16.2% above the current price. Wall Street's consensus target is $635.00 across 28 analysts. RSI at 59 is in neutral territory, and the price is above its 50-day average of $512.07.
Ulta Beauty, Inc. (ULTA)
Ulta Beauty, Inc. NASDAQ
ULTA Price Analysis
Market Metrics
Peer Benchmarking
Valuation vs Sector (Consumer Cyclical)
Performance vs XRT
Sector Position Analysis
ULTA Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
ULTA Analysis
- Monitor insider transactions closely, as recent selling activity has triggered a 'Moderate Sell Signal'.
- Consider the stock's position relative to its 200-day moving average; a sustained move above $557.08 would be a positive technical confirmation.
- Given the competitive retail landscape, focus on Ulta's ability to maintain market share and adapt to evolving consumer trends.
Projected revenue growth of 7.00% for the current year and 5.00% for the next year provides a solid fundamental backdrop for potential stock appreciation.
Source: Wall Street EstimatesA significant majority of Wall Street analysts maintain 'Buy' or 'Strong Buy' ratings, with a median price target of $635.00, indicating confidence in the company's future performance.
Source: Wall Street SummaryRecent insider transactions show net selling activity, with over $1 million in sales compared to approximately $500,000 in purchases, signaling potential caution among management.
Source: Insider TransactionsThe stock is currently trading below its 200-day SMA of $557.08, which is acting as resistance, suggesting a need for further positive momentum to confirm a bullish technical trend.
Source: Technical AnalysisKey Statistics
| Market Cap | 22.90B |
|---|---|
| P/E Ratio | 19.50 |
| EPS (TTM) | 27.47 |
| Dividend Yield | 0.00% |
| 52 Week High | 714.97 |
| 52 Week Low | 443.60 |
Earnings & Growth Analysis
Key Risks
Technical Indicators
| RSI (14) | 59.22 |
|---|---|
| MACD | 9.06 |
| SMA 50 | 512.07 |
| SMA 200 | 557.08 |
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
ULTA Trade Plans
Specific entry, exit, and risk management levels
🟢 LONG ENTRY (click to switch)
Risk Management
Profit Targets (Based on Conservative Entry)
Growth of $10,000
A $10,000 investment in ULTA in September 2016 would be worth about $22,098 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ULTA today could grow to about $21,075 by 2036 in the base case, with a bull case near $102,506 and a bear case around $4,333. Projections are statistical simulations, not guarantees.
ULTA Stock Price Prediction: 2030
CleaRank's simulation projects a price near $737 for ULTA by 2030 in the base case, from $547 today (1.3x over 4 years). The downside path ends near $271. These are outcomes of a Monte Carlo simulation run on ULTA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $357 | $589 | $971 |
| 2028 | $313 | $635 | $1,287 |
| 2029 | $287 | $684 | $1,626 |
| 2030 | $271 | $737 | $2,003 |
| 2031 | $259 | $794 | $2,429 |
| 2032 | $251 | $855 | $2,911 |
| 2033 | $245 | $921 | $3,460 |
| 2034 | $241 | $992 | $4,085 |
| 2035 | $238 | $1,069 | $4,795 |
| 2036 | $237 | $1,152 | $5,604 |
Method: 10,000 simulated price paths using ULTA's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
ULTA Insider Trading Analysis
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 25, 2021 | HEILBRONN CHARLES
Director
|
Sell | 427.0K | $130.4M |
| Mar 29, 2021 | HEILBRONN CHARLES
Director
|
Sell | 402.7K | $122.9M |
| Apr 9, 2021 | HEILBRONN CHARLES
Director
|
Sell | 280.8K | $90.1M |
| Mar 20, 2019 | HEILBRONN CHARLES
Director
|
Sell | 242.4K | $81.2M |
| Mar 22, 2019 | HEILBRONN CHARLES
Director
|
Sell | 162.5K | $54.4M |
| Apr 7, 2021 | HEILBRONN CHARLES
Director
|
Sell | 155.1K | $49.2M |
| Apr 13, 2021 | HEILBRONN CHARLES
Director
|
Sell | 140.5K | $46.1M |
| Mar 19, 2019 | DILLON MARY N
Chief Executive Officer
|
Sell | 120.9K | $40.4M |
| Mar 30, 2021 | HEILBRONN CHARLES
Director
|
Sell | 120.9K | $37.4M |
| Jun 4, 2021 | DILLON MARY N
Director
|
Sell | 81.7K | $26.6M |
